Magazine Stand

Blue Cove Capital is a leading boutique financial planning practice that provides innovative, non-biased strategic advice to a diverse client base nationwide. We assist our clients in achieving their financial objectives by offering comprehensive integrated planning services pertaining to all areas of the financial landscape. Our dynamic advisory practice supports clients through all phases of the financial planning cycle through expert capabilities in Wealth Accumulation, Asset Allocation, Tax Diversification, Capital Preservation, Retirement Distribution, Legacy Planning and Risk Management.

Anavex Life Sciences Corp. is a biopharmaceutical company based in New York, NY, dedicated to developing novel small molecule treatments for challenging central nervous system diseases such as Alzheimer's disease, Parkinson's disease, and rare conditions like Rett syndrome. Through its proprietary SIGMACEPTOR platform, the company targets the Sigma-1 receptor (SIGMAR1) to potentially enhance the body's own defenses against neurodegeneration. With an emphasis on precision medicine, Anavex focuses on addressing the needs of patients and caregivers affected by neurodegenerative and neurodevelopmental disorders. Their investigational drug, ANAVEX 2-73 (blarcamesine), aims to improve autophagy and restore neural cell homeostasis, with ongoing efforts to engage with the community and ensure access to new treatment paradigms. Generated from the website